Related references
Note: Only part of the references are listed.Protein-Bound Uremic Toxins Induce Tissue Remodeling by Targeting the EGF Receptor
Chiao-Yin Sun et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1
Sue C. Bodine et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2014)
Myostatin and the skeletal muscle atrophy and hypertrophy signaling pathways
J. Rodriguez et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
Mechanisms of muscle wasting in chronic kidney disease
Xiaonan H. Wang et al.
NATURE REVIEWS NEPHROLOGY (2014)
DPP-4 Inhibitor Attenuates Toxic Effects of Indoxyl Sulfate on Kidney Tubular Cells
Wei-Jie Wang et al.
PLOS ONE (2014)
The Aryl Hydrocarbon Receptor-Activating Effect of Uremic Toxins from Tryptophan Metabolism: A New Concept to Understand Cardiovascular Complications of Chronic Kidney Disease
Marion Sallee et al.
TOXINS (2014)
Stat3 Activation Links a C/EBPδ to Myostatin Pathway to Stimulate Loss of Muscle Mass
Liping Zhang et al.
CELL METABOLISM (2013)
Activation of Aryl Hydrocarbon Receptor Mediates Indoxyl Sulfate-Induced Monocyte Chemoattractant Protein-1 Expression in Human Umbilical Vein Endothelial Cells
Ippei Watanabe et al.
CIRCULATION JOURNAL (2013)
Cellular and molecular mechanisms of muscle atrophy
Paolo Bonaldo et al.
DISEASE MODELS & MECHANISMS (2013)
Opposite roles of myocardin and atrogin-1 in L6 myoblast differentiation
Yulan Jiang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
p-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase
Hiroshi Watanabe et al.
KIDNEY INTERNATIONAL (2013)
Mortality Prediction by Surrogates of Body Composition: An Examination of the Obesity Paradox in Hemodialysis Patients Using Composite Ranking Score Analysis
Kamyar Kalantar-Zadeh et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2012)
Identification of atrogin-1-targeted proteins during the myostatin-induced skeletal muscle wasting
Sudarsanareddy Lokireddy et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2012)
Suppression of Klotho expression by protein-bound uremic toxins is associated with increased DNA methyltransferase expression and DNA hypermethylation
Chiao-Yin Sun et al.
KIDNEY INTERNATIONAL (2012)
Inhibition of Xanthine Oxidase by Allopurinol Prevents Skeletal Muscle Atrophy: Role of p38 MAPKinase and E3 Ubiquitin Ligases
Frederic Derbre et al.
PLOS ONE (2012)
Interaction between Two Sulfate-Conjugated Uremic Toxins, p-Cresyl Sulfate and Indoxyl Sulfate, during Binding with Human Serum Albumin
Hiroshi Watanabe et al.
DRUG METABOLISM AND DISPOSITION (2012)
Modulation of reactive oxygen species in skeletal muscle by myostatin is mediated through NF-κB
Sandhya Sriram et al.
AGING CELL (2011)
Angiotensin II, Oxidative Stress and Skeletal Muscle Wasting
Sergiy Sukhanov et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2011)
Angiotensin II induced catabolic effect and muscle atrophy are redox dependent
Laura C. Semprun-Prieto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease
Liping Zhang et al.
FASEB JOURNAL (2011)
IL-1β Receptor Antagonist Reduces Inflammation in Hemodialysis Patients
Adriana M. Hung et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Apoptosis and myostatin mRNA are upregulated in the skeletal muscle of patients with chronic kidney disease
Daniela Verzola et al.
KIDNEY INTERNATIONAL (2011)
Organic anion transporters play an important role in the uptake of p-cresyl sulfate, a uremic toxin, in the kidney
Yohei Miyamoto et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
The role and regulation of MAFbx/atrogin-1 and MuRF1 in skeletal muscle atrophy
Victoria C. Foletta et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2011)
Role of Indoxyl Sulfate in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Experimental and Clinical Effects of Oral Sorbent AST-120
Toshimitsu Niwa
THERAPEUTIC APHERESIS AND DIALYSIS (2011)
The Uremic Toxin 3-Indoxyl Sulfate Is a Potent Endogenous Agonist for the Human Aryl Hydrocarbon Receptor
Jennifer C. Schroeder et al.
BIOCHEMISTRY (2010)
Inflammation and cachexia in chronic kidney disease
Wai W. Cheung et al.
PEDIATRIC NEPHROLOGY (2010)
Smad2 and 3 transcription factors control muscle mass in adulthood
Roberta Sartori et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2009)
Identification of MAFbx as a myogenin-engaged F-box protein in SCF ubiquitin ligase
Misako Jogo et al.
FEBS LETTERS (2009)
Muscle atrophy, inflammation and clinical outcome in incident and prevalent dialysis patients
Juan Jesus Carrero et al.
CLINICAL NUTRITION (2008)
Dioxin receptor is a ligand-dependent E3 ubiquitin ligase
Fumiaki Ohtake et al.
NATURE (2007)
Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NF-κB-independent, FoxO1-dependent mechanism
Craig McFarlane et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
Differential contributions of rOat1 (Slc22a6) and rOat3 (Slc22a8) to the in vivo renal uptake of uremic toxins in rats
T Deguchi et al.
PHARMACEUTICAL RESEARCH (2005)
Mechanisms of disuse muscle atrophy: role of oxidative stress
SK Powers et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2005)
Resting energy expenditure and subsequent mortality risk in peritoneal dialysis patients
AYM Wang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Characterization of uremic toxin transport by organic anion transporters in the kidney
T Deguchi et al.
KIDNEY INTERNATIONAL (2004)
Conditional activation of Akt in adult skeletal muscle induces rapid hypertrophy
KMV Lai et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Identification of ubiquitin ligases required for skeletal muscle atrophy
SC Bodine et al.
SCIENCE (2001)
Share Paper
